Aims. The aims of this study were to assess quality of life after
Aims. The aim of this study was to examine perioperative blood transfusion practice, and associations with clinical outcomes, in a national cohort of
Aims. The aim of this study was to determine the impact of hospital-level service characteristics on
Aims. National
Aims. The aim of this study was to explore current use of the Global Fragility Fracture Network (FFN) Minimum Common Dataset (MCD) within established national
Aims.
Aims. Prior to the availability of vaccines, mortality for
Aims. Current levels of
Aims. This study aimed to identify risk factors (patient, healthcare system, and socioeconomic) for mortality after
Aims. Factors associated with high mortality rates in geriatric
Aims. Surgery is often delayed in patients who sustain a
Aims. The primary aim was to assess the independent influence of coronavirus disease (COVID-19) on 30-day mortality for patients with a
Aims. We assessed the value of the Clinical Frailty Scale (CFS) in the prediction of adverse outcome after
Aims. The aim of this study was to investigate the association between additional rehabilitation at the weekend, and in-hospital mortality and complications in patients with
Aims. The use of multimodal non-opioid analgesia in
Aims. The aim of this study was to assess the association of mortality and reoperation when comparing cemented and uncemented hemiarthroplasty (HA) in
Aims. To assess the safety of tranexamic acid (TXA) in a large cohort of patients aged over 65 years who have sustained a
Aims. Echocardiography is commonly used in
Aims. The aim of this study to compare 30-day survival and recovery of mobility between patients mobilized early (on the day of, or day after surgery for a hip fracture) and patients mobilized late (two days or more after surgery), and to determine whether the presence of dementia influences the association between the timing of mobilization, 30-day survival, and recovery. Methods. Analysis of the National
Aims. To compare the cost-effectiveness of high-dose, dual-antibiotic cement versus single-antibiotic cement for the treatment of displaced intracapsular